CVS rebuffs oversight monitor as D.C. court reviews Aetna deal | FierceHealthcare

CVS rebuffs oversight monitor as D.C. court reviews Aetna deal | FierceHealthcare: CVS told a D.C. district court Thursday that a court-appointed monitor is unnecessary to ensure the company keeps Aetna's operations separate as the court reviews the $69 billion transaction. The company offered to submit sworn quarterly declarations indicating it is keeping certain aspects of Aetna's business separate.